Gemeinsame Erklärung von CSG-BIO (Myrisoph Capital) und PBKM (FamiCord Group)

Dubai, Geneve, Warsaw, Leipzig 2025

Gemeinsame Erklärung von CSG-BIO (Myrisoph Capital) und PBKM (FamiCord Group)

We are thrilled to announce that a group of legal entities controlled by Myrisoph Capital Inc (CSG-BIO SA, CellSave Arabia FZ-LLC, and others) and PBKM sp. z o.o. (FamiCord Group) reached a strategic agreement. The parties have clarified all the legal disputes among them as well as the status of cord blood and tissue samples previously under the care of the bankrupt Swiss Company Cryo-Save AG which were transferred to PBKM in 2019 from several locations in Europe.

Our partnership is driven by our shared commitment to providing the highest standard of service for families across Europe and the Middle East. Clients of the bankrupt Swiss Company Cryo-Save AG (or its subsidiaries, such as Salveo, Genico, CrioCord, CryoCare, and others), as well as clients of former CryoSave partners that have ceased operations (e.g., Genico), who wish to continue storing their cord blood and/or cord tissue samples should contact FamiCord Group without delay at https://famicordcryobank.ch/contact-for-clients-of-the-former-service-provider/check-your-sample or at info@famicordcryobank.ch to arrange and confirm the terms for continued storage.

If you are a client of Cryo-Save Arabia FZ-LLC – kindly contact CellSave Arabia FZ-LLC at customerservice@cellsave.com

We strongly recommend that all the clients of bankrupted Swiss Company Cryo-Save AG act promptly to secure the continued care of their samples. Furthermore, we would like to clarify that any other company claiming to hold for and on behalf of the Swiss Company Cryo-Save AG clients’ cord blood or cord tissue units, or invoicing for their storage, is doing so without a legitimate legal basis.

CellSave Arabia FZ-LLC; CSG-BIO; Myrisoph Capital Inc.; PBKM sp. z o.o. ; FamiCord AG

The content of the statement is also available at the link: Statment CSG-BIO and PBKM FamiCord